• Mashup Score: 0
    Wolters Kluwer Health - 10 month(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Did you know: Historical #redlining is independently associated with community-level #stroke risk among #NewYorkCity residents, beyond recognized social determinants of health: https://t.co/TG6irJMA91 #neurotwitter #HealthDisparity #RacialDisparity @AANMember https://t.co/6o3BdD2Lgs

  • Mashup Score: 0

    This cohort study analyzes data from representative private, military, and public health insurance data sets to calculate the national prevalence of multiple sclerosis among Hispanic, non-Hispanic Black, and non-Hispanic White individuals in the United States.

    Tweet Tweets with this article
    • Non-Hispanic White people had the highest overall prevalence of #MultipleSclerosis in the United States, according to a cohort study in @JAMANeuro: https://t.co/ZkU9aHO63l #neurotwitter #MS #RacialDisparity @AANMember https://t.co/ftuljIIJbP

  • Mashup Score: 2

    Background and objectives: Racial and ethnic minorities have been underrepresented in Parkinson’s disease (PD) research, limiting our understanding of treatments and outcomes across all non-White groups. The goal of this research is to investigate variability in health-related quality of life (HRQoL), and other outcomes in patients with PD across different races and ethnicities. Methods: This…

    Tweet Tweets with this article
    • Via @GreenJournal: Among people with #Parkinsons, total PDQ-39 scores were significantly worse in African Americans, Hispanics, and Asians versus White patients: https://t.co/bpHNnO4Q2y #neurotwitter #RacialDisparity @AANMember https://t.co/whUhaRygow

  • Mashup Score: 0

    The issue of racial inequity in health care is complex and multifactorial, and researchers have been working to isolate specific factors involved in these disparities.A study from researchers at Rutgers University suggests that in cases of pediatric cancer, the neighborhood in which a child lives has more of an effect on cancer outcomes than race and ethnicity alone.

    Tweet Tweets with this article
    • Neighborhood factors may drive racial disparities in pediatric cancer outcomes. https://t.co/XcBB45N7YS #RaceandMedicine @RutgersU #pediatriccancers #racialdisparity #HemOnc #OncAlert #MedEd

  • Mashup Score: 0

    Black women in the U.S. appeared less likely than white women to receive guideline-concordant treatment for ovarian cancer, according to a study published in Journal of the National Comprehensive Cancer Network. Even among white women, the vast majority — more than 75% — did not receive surgery and chemotherapy as recommended by National Comprehensive Cancer Network guidelines for

    Tweet Tweets with this article
    • Black women LESS LIKELY to receive guideline-concordant therapy for ovarian cancer. https://t.co/LqWBuZJG07 #womenshealth #ovariancancer #blackwomen #HemOnc #RaceandMedicine @DukeCancer @DukeU #clinicalguidelines #racialdisparity

  • Mashup Score: 0

    Results of a phase 1/phase 2 study showed similar treatment outcomes among Black and non-Black women who received durvalumab plus chemotherapy prior to surgery for triple-negative breast cancer.Data published in Clinical Cancer Research revealed no statistically significant differences in efficacy outcomes according to race and no additional treatment-related adverse events.

    Tweet Tweets with this article
    • #BreastCancerAwarenessMonth ICYMI: Neoadjuvant immunotherapy effective regardless of race in triple-negative #breastcancer. https://t.co/lFwu0YGam3 #durvalumab #neoadjuvanttherapy @YaleCancer @YaleMed #racialdisparity #HemOnc #Oncology #MedEd

  • Mashup Score: 0

    Black women with advanced-stage hormone receptor-positive breast cancer experienced poor response to treatment with neoadjuvant endocrine therapy compared with white women with similar disease presentation, according to study results.The findings, presented during American Association for Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the

    Tweet Tweets with this article
    • #BreastCancerAwarenessMonth ICYMI: Responses to neoadjuvant endocrine therapy for advanced breast cancer differ by race. https://t.co/XcnfVSUQGA #womenshealth #breastcancer @AACR #endocrinetherapy @cityofhope #healthdisparity #racialdisparity